-
1
-
-
84860516573
-
Carbapenem resistance in Enterobacteriaceae: here is the storm!
-
Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012; 18: 263-72.
-
(2012)
Trends Mol Med
, vol.18
, pp. 263-272
-
-
Nordmann, P.1
Dortet, L.2
Poirel, L.3
-
2
-
-
84867166640
-
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions
-
Tzouvelekis LS, Markogiannakis A, Psichogiou M et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25: 682-707.
-
(2012)
Clin Microbiol Rev
, vol.25
, pp. 682-707
-
-
Tzouvelekis, L.S.1
Markogiannakis, A.2
Psichogiou, M.3
-
3
-
-
84930486688
-
Global spread of carbapenemaseproducing Enterobacteriaceae
-
Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8.
-
(2011)
Emerg Infect Dis
, vol.17
, pp. 1791-1798
-
-
Nordmann, P.1
Naas, T.2
Poirel, L.3
-
4
-
-
84882712084
-
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
-
Munoz-Price LS, Poirel L, Bonomo RA et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13: 785-96.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 785-796
-
-
Munoz-Price, L.S.1
Poirel, L.2
Bonomo, R.A.3
-
5
-
-
84859913969
-
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
-
Cantón R, Akóva M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-31.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 413-431
-
-
Cantón, R.1
Akóva, M.2
Carmeli, Y.3
-
8
-
-
84896940320
-
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
-
Daikos GL, Tsaousi S, Tzouvelekis LS et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58: 2322-8.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 2322-2328
-
-
Daikos, G.L.1
Tsaousi, S.2
Tzouvelekis, L.S.3
-
9
-
-
84908528845
-
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
-
pii=20939
-
Monaco M, Giani T, Raffone M et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19: pii=20939.
-
(2014)
Euro Surveill
, vol.19
-
-
Monaco, M.1
Giani, T.2
Raffone, M.3
-
10
-
-
84877700761
-
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
-
Wiskirchen DE, Crandon JL, Nicolau DP. Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae. Int J Antimicrob Agents 2013; 41: 582-5.
-
(2013)
Int J Antimicrob Agents
, vol.41
, pp. 582-585
-
-
Wiskirchen, D.E.1
Crandon, J.L.2
Nicolau, D.P.3
-
11
-
-
84880317088
-
Efficacy of humanized carbapenem exposures against New Delhi metallo-b-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model
-
Wiskirchen DE, Nordmann P, Crandon JL et al. Efficacy of humanized carbapenem exposures against New Delhi metallo-b-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model. Antimicrob Agents Chemother 2013; 57: 3936-40.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 3936-3940
-
-
Wiskirchen, D.E.1
Nordmann, P.2
Crandon, J.L.3
-
12
-
-
78049319835
-
Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases
-
Mammeri H, Guillon H, Eb F et al. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases. Antimicrob Agents Chemother 2010; 54: 4556-60.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4556-4560
-
-
Mammeri, H.1
Guillon, H.2
Eb, F.3
-
13
-
-
84926465439
-
Heterogeneous hydrolytic features for OXA-48-like β-lactamases
-
Oueslati S, Nordmann P, Poirel L. Heterogeneous hydrolytic features for OXA-48-like β-lactamases. J Antimicrob Chemother 2015; 70: 1059-63.
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 1059-1063
-
-
Oueslati, S.1
Nordmann, P.2
Poirel, L.3
-
14
-
-
84924068166
-
Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24
-
CLSI, Wayne, PA, USA
-
Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
-
(2014)
-
-
-
15
-
-
80052883915
-
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
-
BerÇot B, Poirel L, Dortet L et al. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. J Antimicrob Chemother 2011; 66: 2295-7.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 2295-2297
-
-
BerÇot, B.1
Poirel, L.2
Dortet, L.3
-
16
-
-
77957795090
-
In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae
-
Elemam A, Rahimian J, Doymaz M. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J Clin Microbiol 2010; 48: 3558-62.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 3558-3562
-
-
Elemam, A.1
Rahimian, J.2
Doymaz, M.3
-
17
-
-
0038601510
-
Synergy, antagonism, and what the chequerboard puts between them
-
Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 1
-
-
Odds, F.C.1
-
18
-
-
80051805279
-
Methods for determining bactericidal activity and antimicrobial interactions: synergy testing, time-kill curves, and population analysis
-
In: Schwalbe R, Steele-Moore L, Goodwin AC, eds. Boca Raton, FL: CRC Press
-
Verma P. Methods for determining bactericidal activity and antimicrobial interactions: synergy testing, time-kill curves, and population analysis. In: Schwalbe R, Steele-Moore L, Goodwin AC, eds. Antimicrobial Susceptibility Testing Protocols. Boca Raton, FL: CRC Press, 2007; 275-98.
-
(2007)
Antimicrobial Susceptibility Testing Protocols
, pp. 275-298
-
-
Verma, P.1
-
19
-
-
0018631560
-
Comparison of techniques for measurement of in vitro antibiotic synergism
-
Norden CW, Wentzel H, Keleti E. Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis 1979; 140: 629-33.
-
(1979)
J Infect Dis
, vol.140
, pp. 629-633
-
-
Norden, C.W.1
Wentzel, H.2
Keleti, E.3
-
20
-
-
84876267557
-
Effectiveness of a doublecarbapenem regimen for infections in humans due to carbapenemaseproducing pandrug-resistant Klebsiella pneumoniae
-
Giamarellou H, Galani L, Baziaka F et al. Effectiveness of a doublecarbapenem regimen for infections in humans due to carbapenemaseproducing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 2388-90.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 2388-2390
-
-
Giamarellou, H.1
Galani, L.2
Baziaka, F.3
-
21
-
-
84877847319
-
Successful ertapenemdoripenem combination treatment of bacteremic ventilatorassociated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae
-
Ceccarelli G, Falcone M, Giordano A et al. Successful ertapenemdoripenem combination treatment of bacteremic ventilatorassociated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 2900-1.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 2900-2901
-
-
Ceccarelli, G.1
Falcone, M.2
Giordano, A.3
-
22
-
-
79956313039
-
Double-carbapenem therapy for carbapenemaseproducing Klebsiella pneumoniae
-
Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemaseproducing Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 3002-4.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 3002-3004
-
-
Bulik, C.C.1
Nicolau, D.P.2
-
23
-
-
84903901479
-
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
-
Oliva A, D'Abramo A, D'Agostino C et al. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother 2014; 69: 1718-20.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 1718-1720
-
-
Oliva, A.1
D'Abramo, A.2
D'Agostino, C.3
-
24
-
-
84862840426
-
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrugresistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
-
Samonis G, Maraki S, Karageorgopoulos DE et al. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrugresistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 2012; 31: 695-701.
-
(2012)
Eur J Clin Microbiol Infect Dis
, vol.31
, pp. 695-701
-
-
Samonis, G.1
Maraki, S.2
Karageorgopoulos, D.E.3
-
25
-
-
84872871981
-
Metallo-b-lactamase structure and function
-
Palzkill T. Metallo-b-lactamase structure and function. Ann N YAcad Sci 2013; 1277: 91-104.
-
(2013)
Ann N YAcad Sci
, vol.1277
, pp. 91-104
-
-
Palzkill, T.1
-
26
-
-
84862585028
-
Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae
-
Thomson KS. Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 4037.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 4037
-
-
Thomson, K.S.1
|